Clincosm LogoSign in Get a demo

Randomized Trial of Trust in Online Videos About Prostate Cancer

Sponsor
NYU Langone Health (Other)
Overall Status
Completed
CT.gov ID
NCT05886751
Collaborator
(none)
3,649
Enrollment
1
Location
8
Arms
4.7
Actual Duration (Months)
782.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The study team will evaluate the impact of video characteristics on health consumers' trust in online videos. Participants will be randomized to watch a video by one of four speakers about prostate cancer screening or clinical trials and complete a questionnaire (approximately 15 minutes total).

Condition or Disease Intervention/Treatment Phase
  • Other: Black Doctor Screening Video
  • Other: White Doctor Screening Video
  • Other: Black Patient Screening Video
  • Other: White Patient Screening Video
  • Other: Black Doctor Clinical Trials Video
  • Other: White Doctor Clinical Trials Video
  • Other: Black Patient Clinical Trials Video
  • Other: White Patient Clinical Trials Video
 N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
3649 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Randomized Trial of Trust in Online Videos About Prostate Cancer
Actual Study Start Date :
Aug 18, 2021
Actual Primary Completion Date :
Jan 7, 2022
Actual Study Completion Date :
Jan 7, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Video About Screening with Black Doctor

Other: Black Doctor Screening Video
Participants will view an online video with a Black doctor speaking about prostate cancer screening.
Experimental: Video About Screening with White Doctor

Other: White Doctor Screening Video
Participants will view an online video with a White doctor speaking about prostate cancer screening.
Experimental: Video About Screening with Black Patient

Other: Black Patient Screening Video
Participants will view an online video with a Black patient speaking about prostate cancer screening.
Experimental: Video About Screening with White Patient

Other: White Patient Screening Video
Participants will view an online video with a White patient speaking about prostate cancer screening.
Experimental: Video about Clinical Trials with Black Doctor

Other: Black Doctor Clinical Trials Video
Participants will view an online video with a Black doctor speaking about prostate cancer clinical trials.
Experimental: Video about Clinical Trials with White Doctor

Other: White Doctor Clinical Trials Video
Participants will view an online video with a White doctor speaking about prostate cancer clinical trials.
Experimental: Video about Clinical Trials with Black Patient

Other: Black Patient Clinical Trials Video
Participants will view an online video with a Black patient speaking about prostate cancer clinical trials.
Experimental: Video about Clinical Trials with White Patient

Other: White Patient Clinical Trials Video
Participants will view an online video with a White patient speaking about prostate cancer clinical trials.

Outcome Measures

Primary Outcome Measures

  1. Level of Trust in the Video [Visit 1 (Day 1)]

    Trust will be reported as a score on a Likert scale and asked as the following question: How much do you trust the information in the video? The total range of score is 1-4, where (1) trust the information completely, (2) trust most of the information, (3) trust some of the information, (4) do not trust the information

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  1. US adult age 40+

  2. Enrolled in Dynata online survey panel

Exclusion Criteria:

  1. Children

  2. Individuals living outside the U.S.

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYU Langone Health New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Stacy Loeb, MD, MSc, PhD(hc), NYU Langone Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT05886751
Other Study ID Numbers:
  • 20-00540
First Posted:
Jun 2, 2023
Last Update Posted:
Jun 2, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by NYU Langone Health
Trust
Additional relevant MeSH terms:
Prostatic Neoplasms

Study Results

No Results Posted as of Jun 2, 2023